Page 3 - Lon Stx News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Lon stx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Lon Stx Today - Breaking & Trending Today
Shield Therapeutics says OTCQX Best Market listing ahead of Accrufer US launch has great potential Shield Therapeutics PLC s (LON:STX), Tim Watts talks to Proactive London about their new US stock market quote on the OTCQX Best Market. This decision is to support the upcoming launch of Accrufer in the US with the aim to increase relevance to US-based investors. Watts explains that they will face no additional reporting requirements as a result of the American listing, therefore the additional costs will be minimal . Watts believes the drug has the potential to reach the realm of £100mln worth of sales in the first three years and then on to 3-400mln by years five or six . ....
Shield Therapeutics looks forward to US launch of Accrufer after transformational year Increasing sales in the US are estimated to turn the monthly cash flow positive between 15-18 months after launch Shield Therapeutics PLC (LON:STX) said it is now well placed for substantial future growth after a “transformational” year. The group said it is on track to launch its iron deficiency lead product Accrufer in the US by the end of June. Increasing sales in the US are estimated to turn the monthly cash flow positive between 15-18 months after launch, with potential for net sales to reach US$100mln in the third year after launch. ....